Waldenström macroglobulinaemia and intestinal lymphangiectasia

Br J Haematol. 2014 Nov;167(3):292. doi: 10.1111/bjh.13041. Epub 2014 Jul 21.

Authors

Rachel E Cooke¹, Renate M Kalnins, Wai Khoon Ho

Affiliation

¹ Department of Haematology, Austin Health, Melbourne, Australia.

PMID: 25039993
DOI: 10.1111/bjh.13041

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Murine-Derived / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bone Marrow / pathology
Cyclophosphamide / administration & dosage
Diarrhea / etiology
Humans
Immunoglobulin M / blood*
Immunoglobulin kappa-Chains / blood*
Immunophenotyping
Lymphangiectasis, Intestinal / diagnostic imaging
Lymphangiectasis, Intestinal / etiology*
Lymphangiectasis, Intestinal / pathology
Lymphangiectasis, Intestinal / physiopathology
Male
Middle Aged
Paraproteins / analysis*
Prednisolone / administration & dosage
Radiography
Rituximab
Vincristine / administration & dosage
Waldenstrom Macroglobulinemia / blood
Waldenstrom Macroglobulinemia / complications*
Waldenstrom Macroglobulinemia / drug therapy

Substances

Antibodies, Monoclonal, Murine-Derived
Immunoglobulin M
Immunoglobulin kappa-Chains
Paraproteins
Rituximab
Vincristine
Cyclophosphamide
Prednisolone

Supplementary concepts

VCP protocol 2